Abstract:Background Drug combination presents a promising approach to surpassing the current efficacy limitations of biological agents in treating inflammatory bowel disease (IBD). Currently, ferroptosis has emerged as a novel therapeutic target for IBD. Macrophages, pivotal immune cells, also play a vital role in regulating iron metabolism within the body. Furthermore, our prior research has demonstrated that distinct macrophage subtypes exhibit varying sensitivity to reactive oxygen species (ROS) which cause ferroptosis. Combining ferroptosis inhibitors with biologics may provide a new therapeutic strategy to break the therapeutic ceiling of IBD treatment. This study aimed to investigate whether ferroptosis inhibitors could enhance the efficacy of infliximab (IFX) in treating IBD. Methods Immunofluorescence staining was used to analyze the changes of M2 macrophages in human colon specimens pre-and post-treatment with IFX. The effect of IFX on M1 and M2 macrophage ferroptosis was investigated by RAW264.7 cell line in vitro. Additionally, the DSS-induced colitis mouse was used to evaluate the impact of ferroptosis inhibitors on IFX efficacy in vivo while further evaluating the effect of combining IFX with ferroptosis inhibitors on ferroptosis of colonic mucosal cells in mice. Immunofluorescence staining was utilized to assess the quantity of M2 macrophages post-treatment in mouse colon tissue. Results We found that in patients who responded to IFX, M2 macrophages increased, whereas this phenomenon was not observed in non-responders, suggesting that the efficacy of IFX was closely related to M2 macrophage. Notably, our in vitro experiments demonstrated that IFX could induce ferroptosis in both M1 and M2 macrophages, while M2 macrophages were more sensitive to ferroptosis than M1. Our in vivo experimental results indicated that the treatment efficacy of IFX in combination with deferoxamine (DFO), the ferroptosis inhibitor, was superior to those using IFX alone by significantly alleviating ferroptosis in the intestinal cells of experimental colitis mice. Furthermore, IFX combined with DFO had a protective effect on M2 macrophages. Conclusions Our study revealed that the ferroptosis inhibitor DFO could augment the therapeutic efficacy of IFX by suppressing the ferroptosis of M2 macrophages, thus providing a novel strategy for overcoming the current therapeutic ceiling of biological therapy for IBD.

Magnolin Alleviated DSS‐induced Colitis by Inhibiting ALOX5‐mediated Ferroptosis

Magnolin inhibits intestinal epithelial cell apoptosis alleviating Crohn's disease-like colitis by suppressing the PI3K/AKT signalling pathway

Magnoflorine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury Via Suppressing NF-κB and MAPK Activation

Magnolol, a Natural Polyphenol, Attenuates Dextran Sulfate Sodium-Induced Colitis in Mice

Magnolol Treatment Attenuates Dextran Sulphate Sodium-Induced Murine Experimental Colitis by Regulating Inflammation and Mucosal Damage.

Monotropein Alleviates Secondary Liver Injury in Chronic Colitis by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome.

α-Lipoic acid alleviates dextran sulfate sodium salt-induced ulcerative colitis via modulating the Keap1-Nrf2 signaling pathway and inhibiting ferroptosis

Improvement of Magnesium Isoglycyrrhizinate on DSS-induced Acute and Chronic Colitis

Flavonoids Extracted from Licorice Prevents Colitis-Associated Carcinogenesis in AOM/DSS Mouse Model

α-mangostin derivatives ameliorated mouse DSS-induced chronic colitis via regulating Th17/Treg balance

Magnolol Preserves the Integrity of the Intestinal Epithelial Barrier and Mitigates Intestinal Injury Through Activation of PPAR Γ in COPD Rat

IDDF2024-ABS-0037 Enhancing the Therapeutic Effect of Infliximab by Inhibiting Ferroptosis of M2 Macrophages on Experimental Colitis

Pinobanksin ameliorated DSS-induced acute colitis mainly through modulation of SLC7A11/glutathione-mediated intestinal epithelial ferroptosis

Alliin, a garlic organosulfur compound, ameliorates gut inflammation through MAPK-NF-κB/AP-1/STAT-1 inactivation and PPAR-γ activation.

Magnoflorine alleviates dextran sulfate sodium-induced ulcerative colitis via inhibiting JAK2/STAT3 signaling pathway

Andrographolide Derivative AL-1 Ameliorates TNBS-induced Colitis in Mice: Involvement of NF-кB and PPAR-γ Signaling Pathways.

Nanotechnology-enabled M2 macrophage polarization and ferroptosis inhibition for targeted inflammatory bowel disease treatment

Protective Effect of Magnolol on Lipopolysaccharide-Induced Acute Lung Injury in Mice

Magnolol ameliorates lipopolysaccharide-induced acute lung injury in rats through PPAR-γ-dependent inhibition of NF-kB activation

Targeting TLR4 and regulating the Keap1/Nrf2 pathway with andrographolide to suppress inflammation and ferroptosis in LPS-induced acute lung injury

Andrographolide Derivative AL-1 Ameliorates Dextran Sodium Sulfate-Induced Murine Colitis by Inhibiting NF-κB and MAPK Signaling Pathways